| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |